Portale Hypertension

Dieser Beitrag soll den aktuellen Stand des Wissens zur Pathophysiologie und Ätiologie der portalen Hypertension darstellen und einen sinnvollen Ansatz zur Patientenevaluation und zum diagnostischen Management vorschlagen. Des Weiteren sollen die wesentlichen primär- und sekundärprophylaktischen Therapiealgorithmen, insbesondere im Hinblick auf die viszeralmedizinisch interventionell und chirurgisch relevante Komplikation einer gastroösophagealen Varizenblutung, aufgezeigt werden.

• Zum Weiterlesen und Vertiefen/Quellenangaben

• Abu-Elmagd KM, Costa G, Bond GJ et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009; 250: 567-581
• Berzigotti A, Seijo S, Reverter E et al. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013; 7: 141-155
• Boyer TD, Henderson JM, Heerey AM et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 2008; 48: 407-414
• Clark W, Hernandez J, McKeon B et al. Surgical shunting versus transjugular intrahepatic portasystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis. Am Surg 2010; 76: 857-864
• Clark W, Golkar F, Luberice K et al. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts?. Am J Surg 2011; 202: 561-564
• Costa G, Cruz jr. RJ, Abu-Elmagd KM. Surgical shunt versus TIPS for treatment of variceal hemorrhage in the current era of liver and multivisceral transplantation. Surg Clin North Am 2010; 90: 891-905
• de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768
• Donadini MP, Dentali F, Ageno W. Splanchnic vein thrombosis: new risk factors and management. Thromb Res 2012; 129 (Suppl. 01) 93-96
• Galloway JR, Henderson JM. Management of variceal bleeding in patients with extrahepatic portal vein thrombosis. Am J Surg 1990; 160: 122-127
• Henderson JM, Boyer TD, Kutner MH et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006; 130: 1643-1651
• Hirner A, Weise K. Chirurgie. Schnitt für Schnitt. Stuttgart: Thieme; 2004: 526-537
• Horton JD, San Miguel FL, Membreno F et al. Budd-Chiari syndrome: illustrated review of current management. Liver Int 2008; 28: 455-466
• McMahon C, Abu-Elmagd K, Bontempo FA et al. JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses. Am J Clin Pathol 2007; 127: 736-743
• Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis 2010; 42: 163-170
• Rosemurgy AS, Zervos EE. Management of variceal hemorrhage. Curr Probl Surg 2003; 40: 263-343
• Rosemurgy AS, Bloomston M, Clark WC et al. H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg 2005; 241: 238-246
• Rosemurgy AS, Frohman HA, Teta AF et al. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial. J Am Coll Surg 2012; 214: 445-453
• Sauerbruch T, Appenrodt B, Schmitz V et al. The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis. Dtsch Arztebl Int 2013; 110: 126-132
• Toomey PG, Ross SB, Golkar FC et al. Outcomes after transjugular intrahepatic portosystemic stent shunt: a “bridge” to nowhere. Am J Surg 2013; 205: 441-446
• Wolff M, Hirner A. [Surgical treatment of portal hypertension]. Zentralbl Chir 2005; 130: 238-245